The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice President has already hit the ground running in this key leadership position to manage the GI medical affairs portfolio and team for Cyramza. The Chase Group proudly connects life-changing companies with executives and would like to congratulate Eli Lilly on securing such a high caliber talent for their Oncology Medical Affairs team. We value our continued partnership, helping Eli Lilly in their mission to change the frontiers of what’s possible in medicine and to provide a new sense of hope for people suffering from some of the world’s most debilitating diseases.
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice President has already hit the ground running in this key leadership position to manage the GI medical affairs portfolio and team for Cyramza. The Chase Group proudly connects life-changing companies with executives and would like to congratulate Eli Lilly on securing such a high caliber talent for their Oncology Medical Affairs team. We value our continued partnership, helping Eli Lilly in their mission to change the frontiers of what’s possible in medicine and to provide a new sense of hope for people suffering from some of the world’s most debilitating diseases.- Categories: Pharmaceutical
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. -
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development… 
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…